Indacaterol: The First Once-daily Long-acting Beta2 Agonist for COPD - Milestones in Drug Therapy - Alexandre Trifilieff - Books - Springer Basel - 9783034807081 - November 27, 2013
In case cover and title do not match, the title is correct

Alexandre Trifilieff
Indacaterol: The First Once-daily Long-acting Beta2 Agonist for COPD - Milestones in Drug Therapy 2014 edition

Price
$ 107.49
excl. VAT

Ordered from remote warehouse

Expected to be ready for shipping Jun 2 - 8

Our customers say:

14-day return policy in accordance with European consumer protection law
Top ranking on Trustpilot
Add to your iMusic wish list

Here is a comprehensive overview of the development of Onbrez Breezhaler, a newly approved once-daily inhaled beta2 agonist for treating COPD. Covers design and pre-clinical pharmacology of the molecule, early clinical development, efficacy studies and more.

146 pages, 20 black & white illustrations, 21 colour illustrations, biography

Media Books     Hardcover Book   (Book with hard spine and cover)
Released November 27, 2013
ISBN13 9783034807081
Publishers Springer Basel
Pages 146
Dimensions 155 × 235 × 15 mm   ·   408 g
Language German  
Editor Trifilieff, Alexandre

See all of Alexandre Trifilieff ( e.g. Hardcover Book )